Clinigence Holdings, Inc. (CLNH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Clinigence Holdings, Inc. (CLNH). Clinigence Holdings, Inc. provides healthcare services, including Medicare management and performance improvement plans. Sector: Healthcare.
Last analyzed: Mar 18, 2026CLNH: 1/1 perspectives are bearish.
Clinigence Holdings, Inc. (CLNH) Healthcare & Pipeline Overview
Clinigence Holdings, Inc. offers healthcare services, specializing in Medicare management and performance metrics, operating within the healthcare information services sector. With a focus on cost improvement and performance enhancement plans, the company caters to healthcare providers seeking operational and financial optimization, demonstrating a solid profit margin of 20.6%.
What Is the Investment Thesis for CLNH?
Clinigence Holdings, Inc. presents a compelling investment case within the healthcare information services sector, driven by its specialized offerings in Medicare management and performance improvement. A key value driver is the company's impressive profit margin of 20.6%, indicating efficient operations and strong pricing power. The P/E ratio of 0.18 suggests potential undervaluation relative to earnings. Growth catalysts include increasing demand for healthcare cost optimization services and potential expansion into new geographic markets. However, investors may want to evaluate the risks associated with operating in the competitive healthcare industry, including regulatory changes and technological advancements. The company's ability to scale its services and maintain its profit margin will be critical to its long-term success.
Based on FMP financials and quantitative analysis
CLNH Key Highlights
- Profit Margin of 20.6% demonstrates strong operational efficiency.
- P/E ratio of 0.18 suggests potential undervaluation compared to industry peers.
- Gross Margin of 50.8% indicates effective cost management and pricing strategies.
- Focus on Medicare management positions the company to benefit from the growing demand for healthcare cost optimization.
- Offers a suite of services including performance metrics, cost improvement plans, and health management services, providing a diversified revenue stream.
Who Are CLNH's Competitors?
Who Are CLNH's Competitors?
CLNH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BTMD biote Corp. | $2.00 | -1.35% | $88.22M | 47 |
| GUERF Guerbet S.A. | $22.25 | +0.00% | $281.03M | 43 |
| HNGE Hinge Health, Inc. | $54.50 | +1.15% | 5B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.00 | +0.00% | $20.00M | 67 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| FOXO FOXO Technologies Inc. | $0.00 | +0.00% | 3K | 63 |
| DOCS Doximity, Inc. | $21.40 | +1.57% | $4.00B | 52 |
| GEHC GE HealthCare Technologies Inc. | $64.67 | -3.05% | $29.42B | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CLNH's Key Strengths?
- Specialized expertise in Medicare management.
- Strong profit margin of 20.6%.
- Customized solutions tailored to specific client needs.
- Data-driven insights and analytics capabilities.
What Are CLNH's Weaknesses?
- Small company size with only 12 employees.
- Limited brand recognition.
- Dependence on a small number of key clients.
- Unknown disclosure status on OTC market.
What Could Drive CLNH Stock Higher?
- Potential partnerships with healthcare providers to expand service offerings.
- Development and launch of AI-powered analytics platform to enhance performance metrics.
- Increasing demand for healthcare cost optimization services due to rising healthcare expenditures.
- Government initiatives promoting value-based care models, driving adoption of Clinigence's solutions.
What Are the Key Risks for CLNH?
- Regulatory changes impacting Medicare management and reimbursement rates.
- Increasing competition from larger healthcare technology companies.
- Technological advancements rendering existing solutions obsolete.
- Limited financial disclosure and liquidity due to trading on the OTC market.
- Dependence on a small number of key clients, creating revenue concentration risk.
What Are the Growth Opportunities for CLNH?
- Expansion into Telehealth Services: Clinigence can leverage its existing infrastructure to offer telehealth services, tapping into the rapidly growing telehealth market, projected to reach $455.3 billion by 2030. This expansion would allow Clinigence to provide remote patient monitoring and virtual consultations, enhancing patient access and reducing healthcare costs. Success depends on integrating telehealth platforms and securing partnerships with healthcare providers.
- Development of AI-Powered Analytics: Investing in AI-powered analytics to enhance its performance metrics and cost improvement plans can provide a significant competitive advantage. The AI in healthcare market is expected to reach $95.65 billion by 2030. By leveraging AI, Clinigence can offer more accurate and personalized insights to healthcare providers, leading to better decision-making and improved patient outcomes. This requires significant investment in data science and AI infrastructure.
- Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals and clinics to integrate Clinigence's services into their existing workflows can drive significant growth. These partnerships would provide Clinigence with access to a larger customer base and enable it to offer customized solutions tailored to specific healthcare settings. Success hinges on building strong relationships and demonstrating the value of Clinigence's services.
- Geographic Expansion: Expanding its services to new geographic markets within the United States can unlock significant growth potential. By targeting regions with high healthcare costs and a growing aging population, Clinigence can capitalize on the increasing demand for cost optimization and performance improvement solutions. This requires careful market research and targeted marketing efforts.
- Acquisition of Complementary Businesses: Acquiring complementary businesses in the healthcare technology space can expand Clinigence's service offerings and market reach. This could include companies specializing in electronic health records (EHRs), revenue cycle management, or patient engagement platforms. Strategic acquisitions would allow Clinigence to offer a more comprehensive suite of services and strengthen its competitive position.
What Opportunities Does CLNH Have?
- Expansion into telehealth services.
- Development of AI-powered analytics.
- Strategic partnerships with healthcare providers.
- Geographic expansion within the United States.
What Threats Does CLNH Face?
- Increasing competition in the healthcare information services sector.
- Regulatory changes impacting Medicare management.
- Technological advancements rendering existing solutions obsolete.
- Economic downturn affecting healthcare spending.
What Are CLNH's Competitive Advantages?
- Specialized expertise in Medicare management.
- Data-driven insights and analytics capabilities.
- Customized solutions tailored to specific client needs.
What Does CLNH Do?
Clinigence Holdings, Inc., incorporated in 2014 and based in Fort Lauderdale, Florida, operates within the healthcare sector, providing a suite of services designed to optimize healthcare operations and financial performance. The company focuses on delivering Medicare management, performance metrics, cost improvement strategies, performance improvement plans, and overall health management services. These offerings are tailored to assist healthcare providers in navigating the complexities of the healthcare landscape, particularly concerning Medicare regulations and financial sustainability. Clinigence aims to improve the efficiency and effectiveness of healthcare delivery through data-driven insights and strategic planning. By offering performance metrics and cost improvement plans, Clinigence enables healthcare organizations to identify areas for improvement and implement targeted solutions. The company's health management services further support providers in enhancing patient care and outcomes, contributing to a more sustainable and value-based healthcare system. While the company is based in Fort Lauderdale, Florida, its services are applicable to healthcare providers across the United States, addressing the universal need for efficient healthcare management and financial optimization.
What Products and Services Does CLNH Offer?
- Provides Medicare management services to healthcare providers.
- Offers performance metrics to track and improve healthcare outcomes.
- Develops cost improvement plans to reduce healthcare expenditures.
- Creates performance improvement plans to enhance operational efficiency.
- Delivers health management services to improve patient care.
- Offers data-driven insights to optimize healthcare delivery.
How Does CLNH Make Money?
- Provides healthcare management services to healthcare providers.
- Generates revenue through service fees and subscriptions.
- Offers customized solutions tailored to specific client needs.
What Industry Does CLNH Operate In?
Clinigence Holdings, Inc. operates in the healthcare information services sector, a market characterized by increasing demand for solutions that improve efficiency, reduce costs, and enhance patient outcomes. The industry is driven by factors such as rising healthcare expenditures, regulatory pressures, and the growing adoption of value-based care models. Competitors include companies like BTMD (BioTelemetry, Inc.), CSSPF (Computer Services, Inc.), DFHL (Dental Future Holding Ltd), DLHTF (Delta Health Systems, Inc.), and GUERF (Guerbet SA), each offering various solutions in the healthcare technology space. Clinigence differentiates itself through its focus on Medicare management and performance improvement plans.
Who Are CLNH's Key Customers?
- Hospitals and clinics seeking to improve their financial performance.
- Healthcare providers looking to optimize their operations.
- Organizations aiming to enhance patient care and outcomes.
CLNH Financials
CLNH Latest News
No recent news available for CLNH.
CLNH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLNH.
Price Targets
Wall Street price target analysis for CLNH.
CLNH MoonshotScore
What does this score mean?
The MoonshotScore rates CLNH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Warren Hosseinion
CEO
Warren Hosseinion serves as the CEO of Clinigence Holdings, Inc., managing a team of 12 employees. His background includes experience in the healthcare sector, with a focus on healthcare management and operational efficiency. He has a track record of implementing strategies to improve financial performance and enhance patient care. Prior to joining Clinigence, Hosseinion held leadership positions in other healthcare organizations, where he focused on streamlining operations and improving profitability.
Track Record: Under Warren Hosseinion's leadership, Clinigence Holdings, Inc. has focused on providing healthcare services, including Medicare management, performance metrics, and cost improvement plans. He has overseen the company's efforts to optimize healthcare operations and financial performance for its clients. Key milestones include maintaining a strong profit margin and expanding the company's service offerings.
CLNH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Clinigence Holdings, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more challenging for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increasing information asymmetry.
- Lower trading volume and liquidity leading to price volatility.
- Higher potential for fraud and manipulation due to less regulatory oversight.
- Increased risk of delisting or suspension from trading.
- Potential for difficulty in obtaining accurate and timely information about the company.
- Verify the company's disclosure status and obtain access to financial reports.
- Assess the company's management team and their track record.
- Review the company's business model and competitive landscape.
- Evaluate the company's financial health and operational performance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 2014.
- Clinigence provides healthcare services, indicating a real business operation.
- The company has a CEO and a team of 12 employees.
Clinigence Holdings, Inc. Healthcare Stock: Key Questions Answered
What does Clinigence Holdings, Inc. do?
Clinigence Holdings, Inc. provides healthcare services focused on optimizing the financial and operational performance of healthcare providers. The company offers Medicare management, performance metrics, cost improvement plans, and overall health management services. By leveraging data-driven insights and strategic planning, Clinigence aims to improve the efficiency and effectiveness of healthcare delivery, enabling healthcare organizations to navigate the complexities of the healthcare landscape and achieve sustainable financial performance.
What do analysts say about CLNH stock?
As of 2026-03-18, there is no readily available analyst coverage specifically for Clinigence Holdings, Inc. (CLNH) stock. Given its OTC listing and smaller market capitalization, the company may not be widely followed by major brokerage firms. Investors should conduct their own thorough research and consider the company's fundamentals, growth prospects, and risk factors before making any investment decisions. The P/E ratio of 0.18 and profit margin of 20.6% may warrant further investigation.
What are the main risks for CLNH?
Clinigence Holdings, Inc. faces several risks, including regulatory changes impacting Medicare management, increasing competition in the healthcare information services sector, and technological advancements rendering existing solutions obsolete. Additionally, the company's limited financial disclosure and liquidity due to trading on the OTC market pose significant challenges for investors. Dependence on a small number of key clients also creates revenue concentration risk, potentially impacting the company's financial stability.
What are the key factors to evaluate for CLNH?
Evaluating CLNH involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Specialized expertise in Medicare management. Primary risk to monitor: Regulatory changes impacting Medicare management and reimbursement rates. This is not financial advice.
How frequently does CLNH data refresh on this page?
CLNH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CLNH's recent stock price performance?
Recent price movement in Clinigence Holdings, Inc. (CLNH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized expertise in Medicare management. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CLNH overvalued or undervalued right now?
Determining whether Clinigence Holdings, Inc. (CLNH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CLNH?
Before investing in Clinigence Holdings, Inc. (CLNH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Lack of analyst coverage may impact the accuracy of the analysis.
- Financial data is based on available information and may not be comprehensive.